Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Silva, Gisele S
ETHICHS, NCT03743103: Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study	Terminated	4	20	RoW	Brevibloc, 10 Mg/mL Intravenous Solution, Brevibloc, Nitroprusside, Sodium, Nitroprus	Cristália Produtos Químicos Farmacêuticos Ltda.	Hemorrhagic Stroke	10/21	10/21
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction	Terminated	3	535	Europe, Canada, Japan, US, RoW	BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo	Remedy Pharmaceuticals, Inc.	Brain Edema, Stroke, Acute	08/23	08/23
EXTEND-IV, NCT05199662: Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT	Recruiting	3	360	RoW	Intravenous tenecteplase, TNK, Metalyse, Placebo	Hospital Moinhos de Vento, Ministry of Health, Brazil, Boehringer Ingelheim, Brainomix Limited, iSchemaView, Inc	Ischemic Stroke, Acute	07/26	07/27
SAPPHIRE-LDL, NCT05622929: Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control	Active, not recruiting	N/A	1465	RoW	Digitally-enabled Multifaceted Quality Improvement Intervention, Usual care	Hospital Israelita Albert Einstein, epHealth primary care solutions, Novartis	Cardiovascular Diseases, Atherosclerosis, Dyslipidemias	12/24	06/25
Laranja, Daniela
No trials found
Valiente, Raul
No trials found